Alliancebernstein L.P. Has $4.36 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Alliancebernstein L.P. decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 16.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,635 shares of the medical instruments supplier's stock after selling 43,737 shares during the period. Alliancebernstein L.P. owned 0.12% of DENTSPLY SIRONA worth $4,358,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB increased its position in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC raised its stake in shares of DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.53 during midday trading on Tuesday, hitting $12.55. The company had a trading volume of 3,114,940 shares, compared to its average volume of 2,949,863. The firm has a 50-day moving average price of $15.95 and a 200-day moving average price of $18.96. The company has a market capitalization of $2.50 billion, a PE ratio of -6.06, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $31.13.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 5.10%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

Analyst Ratings Changes

A number of brokerages have weighed in on XRAY. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Barrington Research cut their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $22.58.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.